Skip to main content

Quillivant XR FDA Approval History

FDA Approved: Yes (First approved September 27, 2012)
Brand name: Quillivant XR
Generic name: methylphenidate
Dosage form: for Extended-Release Oral Suspension
Company: NextWave Pharmaceuticals, Inc.
Treatment for: ADHD

Quillivant XR (methylphenidate) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

Development timeline for Quillivant XR

Oct  1, 2012Approval NextWave Pharmaceuticals Receives FDA Approval of Quillivant XR for Once-Daily Treatment of ADHD

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.